Literature DB >> 26180936

Indirect Back-Titration ELISA: A New Format for Estimation of Human Tissue Kallikreins.

Faiz-Ul-Hassan Nasim1, Samina Ejaz, Muhammad Ashraf, Gulzar Ahmad.   

Abstract

Enzyme-linked immunosorbent assay (ELISA) is either based on sandwich, competitive, or inhibition type of format. However, these formats need 2 or 3 monoclonal antibodies (moAB) to estimate 1 antigen. To get a cost-effective, high throughput, ELISA for estimation of human tissue kallikreins we have now developed an indirect, back-titration style, Time Resolved ImmunoFluorometric (TRIF) ELISA that uses only 1 antigen-specific moAB and a general polyclonal antibody. Polystyrene microtiter plate wells coated with a capture antibody, a mouse moAB prepared against a specific human tissue kallikrein are allowed to interact either with the corresponding pure antigen, as the calibrator, or with the corresponding antigen present in a biological fluid or tissue extract. The detection antibody, anti-mouse IgG conjugated with alkaline phosphatase, is added to find the antigen-free immobilized capture moAB. Conjugated enzyme is allowed to hydrolyze diflunisal phosphate to produce a highly fluorescent complex. The fluorescence measured in TRIF mode corresponds to the antigen-free immobilized capture moAB and is used to quantify antigen-bound capture moAB. The detection antibody binds with the antigen-free capture moAB and strength of the signal correlates inversely with the amount of antigen bound to the capture moAB. With a minimum detection level of 20 ng/L the assay has no cross-reactivity with several test molecules. The method is sensitive, specific, applicable to a variety of biological samples, and cost-effective as it uses only 1 moAB and a polyclonal antibody. Using this assay, a single epitope can be estimated without purification.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26180936     DOI: 10.1097/PAI.0000000000000150

Source DB:  PubMed          Journal:  Appl Immunohistochem Mol Morphol        ISSN: 1533-4058


  1 in total

1.  Down-regulation of hK7 in the sera of breast cancer and benign breast disease patients.

Authors:  Samina Ejaz; Faiz-Ul-Hassan Nasim; Muhammad Ashraf; Gulzar Ahmad
Journal:  Heliyon       Date:  2017-07-17
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.